• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝海绵状血管瘤:长期无增大。

Hepatic cavernous hemangiomas: lack of enlargement over time.

作者信息

Mungovan J A, Cronan J J, Vacarro J

机构信息

Department of Diagnostic Imaging, Rhode Island Hospital, Providence 02903.

出版信息

Radiology. 1994 Apr;191(1):111-3. doi: 10.1148/radiology.191.1.8134554.

DOI:10.1148/radiology.191.1.8134554
PMID:8134554
Abstract

PURPOSE

To determine whether change in size is a characteristic of cavernous hemangioma of the liver.

MATERIALS AND METHODS

Twenty-one focal masses in 21 patients were diagnosed as cavernous hemangiomas with imaging-guided percutaneous fine-needle biopsy performed between 2 weeks and 2 months after initial imaging study (computed tomography [CT] or ultrasonography [US]). Follow-up imaging examinations (CT, US, or magnetic resonance imaging plus US) were obtained at 5-84 months in all patients.

RESULTS

The cavernous hemangiomas ranged in size from 1.5 to 13.5 cm. At follow-up imaging, 19 (90%) of 21 lesions had not changed in size; the two remaining lesions increased by 1 and 2 cm over 3 and 10 months, respectively.

CONCLUSION

The size of the majority of cavernous hemangiomas remains stable for periods of follow-up ranging from 5 to 84 months. Growth of these lesions is not characteristic and, when it occurs, should prompt reassessment of the diagnosis.

摘要

目的

确定大小变化是否为肝海绵状血管瘤的一个特征。

材料与方法

21例患者中的21个局灶性肿块经影像学引导下经皮细针穿刺活检诊断为海绵状血管瘤,穿刺活检在初次影像学检查(计算机断层扫描[CT]或超声[US])后2周2个月进行。所有患者在584个月时进行了随访影像学检查(CT、US或磁共振成像加US)。

结果

海绵状血管瘤大小在1.5至13.5厘米之间。在随访影像学检查中,21个病灶中有19个(90%)大小未变;其余两个病灶在3个月和10个月内分别增大了1厘米和2厘米。

结论

大多数海绵状血管瘤在5至84个月的随访期内大小保持稳定。这些病灶的生长并非其特征性表现,一旦出现生长,应促使重新评估诊断。

相似文献

1
Hepatic cavernous hemangiomas: lack of enlargement over time.肝海绵状血管瘤:长期无增大。
Radiology. 1994 Apr;191(1):111-3. doi: 10.1148/radiology.191.1.8134554.
2
Hepatic cavernous hemangioma in patients at high risk for liver cancer.肝癌高危患者的肝海绵状血管瘤。
Acta Radiol. 1987 Nov-Dec;28(6):697-701.
3
The radiology of cavernous hemangioma of the liver.肝脏海绵状血管瘤的放射学
Crit Rev Diagn Imaging. 1990;30(1):1-18.
4
Hepatic cavernous hemangioma: magnetic resonance imaging. Work in progress.
Radiology. 1985 May;155(2):417-20. doi: 10.1148/radiology.155.2.3983393.
5
Atypical cavernous hemangioma of the liver.肝脏非典型海绵状血管瘤。
Radiat Med. 1988 May-Jun;6(3):135-40.
6
Hepatic cavernous hemangiomas: long-term (> 5 years) follow-up changes on contrast-enhanced dynamic computed tomography or magnetic resonance imaging and determinant factors of the size change.肝海绵状血管瘤:增强动态 CT 或 MRI 的长期 (> 5 年)随访变化及大小变化的决定因素。
Radiol Med. 2018 May;123(5):323-330. doi: 10.1007/s11547-018-0854-y. Epub 2018 Jan 22.
7
Hepatic cavernous hemangioma: appearance on T2-weighted fast spin-echo MR imaging with and without fat suppression.肝海绵状血管瘤:在有和没有脂肪抑制的T2加权快速自旋回波磁共振成像上的表现
AJR Am J Roentgenol. 1997 Feb;168(2):461-5. doi: 10.2214/ajr.168.2.9016227.
8
Distinction between cavernous hemangiomas of the liver and hepatic metastases on CT: value of contrast enhancement patterns.肝脏海绵状血管瘤与肝转移瘤在CT上的鉴别:对比增强模式的价值
AJR Am J Roentgenol. 1995 Mar;164(3):625-9. doi: 10.2214/ajr.164.3.7863883.
9
Hemangioma in the cirrhotic liver: diagnosis and natural history.肝硬化肝脏中的血管瘤:诊断与自然病程
Radiology. 2001 Apr;219(1):69-74. doi: 10.1148/radiology.219.1.r01ap3269.
10
Hepatic cavernous hemangioma in cirrhotic liver: imaging findings.肝硬化肝脏中的肝海绵状血管瘤:影像学表现
Korean J Radiol. 2000 Oct-Dec;1(4):185-90. doi: 10.3348/kjr.2000.1.4.185.

引用本文的文献

1
Evaluation of Predictive Factors for Transarterial Bleomycin-Lipiodol Embolization Success in Treating Giant Hepatic Hemangiomas.经动脉注射博来霉素-碘油栓塞术治疗巨大肝血管瘤成功的预测因素评估
Cancers (Basel). 2024 Dec 26;17(1):42. doi: 10.3390/cancers17010042.
2
A Case Report: Giant Liver Hemangioma Treated with Transcatheter Embolization.病例报告:经导管栓塞治疗巨大肝血管瘤
Cureus. 2024 Aug 1;16(8):e65927. doi: 10.7759/cureus.65927. eCollection 2024 Aug.
3
Hepatic Hemangioma: Review of Imaging and Therapeutic Strategies.肝血管瘤:影像学及治疗策略综述。
Medicina (Kaunas). 2024 Mar 8;60(3):449. doi: 10.3390/medicina60030449.
4
Transarterial Bleomycin-Lipiodol Chemoembolization for the Treatment of Giant Hepatic Hemangiomas: An Assessment of Effectiveness.经动脉注射博来霉素-碘油化疗栓塞术治疗巨大肝血管瘤:疗效评估
Cancers (Basel). 2024 Jan 16;16(2):380. doi: 10.3390/cancers16020380.
5
Hepatic hemangioma: proportion and predictor of surgical treatment with emphasis on its growth rate.肝血管瘤:手术治疗的比例和预测因素,重点关注其生长速度。
Korean J Intern Med. 2023 Nov;38(6):818-830. doi: 10.3904/kjim.2023.062. Epub 2023 Nov 1.
6
Surgical management of giant hepatic hemangioma: A 10-year single center experience.巨大肝血管瘤的外科治疗:单中心10年经验
Ann Med Surg (Lond). 2021 Jul 6;69:102542. doi: 10.1016/j.amsu.2021.102542. eCollection 2021 Sep.
7
Proton beam therapy for a giant hepatic hemangioma: A case report and literature review.质子束治疗巨大肝血管瘤:一例报告及文献综述。
Clin Transl Radiat Oncol. 2021 Feb 3;27:152-156. doi: 10.1016/j.ctro.2021.01.014. eCollection 2021 Mar.
8
Five common errors to avoid in clinical practice: the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) Choosing Wisely Campaign.避免临床实践中常见的 5 个错误:意大利医院胃肠病学家和内镜医师协会(AIGO)明智选择活动。
Intern Emerg Med. 2019 Mar;14(2):301-308. doi: 10.1007/s11739-018-1992-x. Epub 2018 Nov 29.
9
Right hepatectomy for giant cavernous hemangioma with diffuse hemangiomatosis around Glisson's capsule.针对肝门部周围伴有弥漫性血管瘤病的巨大海绵状血管瘤行右半肝切除术。
World J Gastroenterol. 2014 Jul 7;20(25):8312-6. doi: 10.3748/wjg.v20.i25.8312.
10
Diagnosis and management of giant hepatic hemangioma: the usefulness of contrast-enhanced ultrasonography.巨大肝血管瘤的诊断与管理:对比增强超声检查的应用价值
Int J Hepatol. 2013;2013:802180. doi: 10.1155/2013/802180. Epub 2013 May 16.